In breast cancer, XIST acts as a tumor suppressor by positively regulating the expression of non-X-chromosome gene PH domain and leucine rich repeat protein phosphatase 1 (PHLPP1), which in turn catalyzes dephosphorylation of protein kinase B (AKT) [125]. Here, AKT1 is linked to neoplasm.